Fidelity® Select Pharmaceuticals Portfolio (FPHAX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.


1 month-4.58% 3 years+20.10%
3 months+1.37% 5 years+24.23%
1 year+28.72% Since inception+8.52%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+24.23%+23.71%
Expense ratio0.85%1.46%
Risk 5 year sharpe ratio1.821.54
Net assets$1.6B$2.6B
Average market cap$50.0B$31.7B
Average P/E25.926.8
Portfolio turnover54%54%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenureAsher Anolic / 0 Years
Minimal initial investment$2,500.00
Minimum IRA investment$200.00


U.S. stock49.36%
International stock49.33%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 98.48%
Hardware 0.61%
Consumer goods 0.39%
Business service 0.00%
Consumer service 0.00%
Top 10 Holdings
Portfolio weighting
ABBV AbbVie Inc6.13%
AZN AstraZeneca PLC ADR5.79%
SNY Sanofi ADR5.72%
ACT Actavis PLC5.68%
NVS Novartis AG ADR5.66%
JNJ Johnson & Johnson5.16%
BMY Bristol-Myers Squibb Company5.01%
PRGO Perrigo Company PLC4.93%
TEVA Teva Pharmaceutical Industries Ltd ADR4.42%
MRK Merck & Co Inc4.41%

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.